HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 10, October 2021 – An Inquiry into Life in the Universe       » A New Cell Factory for High-Purity DHA Production       » A New Nanoplatform With Dual-Mode Therapeutic Pathways       » Improving Breast Cancer Detection With New Liquid Biopsy Diagnosis Model       » Alginic Acid: The Secret to Building Better Bones       » Next Generation Genome Engineering With Mini CRISPR — Made Smaller to Deliver Better      
Vol 25, No. 10, October 2021   |   Issue PDF view/purchase
INSIDE INDUSTRY
Digital Health Platform Doctor Anywhere Closes S$88 Million Series C Round to Deepen Southeast Asia Expansion
The investment will significantly bolster Doctor Anywhere’s market leadership and its mission to transform the regional healthcare landscape through technology.

Doctor Anywhere (DA), a regional tech-led healthcare company headquartered in Singapore, announced in August that it has raised its Series C financing round, led by growth equity investor Asia Partners. The round also attracted other investors including Novo Holdings, Philips and OSK-SBI Venture Partners.

At S$88 million (US$65.7 million), it is one of the largest private funding rounds ever raised by a health tech company in Southeast Asia.

Existing investors also participated in the round, including Singapore-based global investor EDBI, Square Peg, IHH Healthcare, Kamet Capital and Pavilion Capital. This round brings the total capital raised by Doctor Anywhere since its founding to more than S$140 million.

As a result of the financing, Oliver Rippel, Co-Founder and Partner of Asia Partners, and Dr. Amit Kakar, Senior Partner, Head of Novo Holdings Equity Asia will come onboard DA’s Board of Directors.

Since its launch in 2017, DA has grown exponentially to serve more than 1.5 million users across Southeast Asia. Over the past 18 months, the COVID-19 pandemic has also served as a catalyst to fast-track the adoption of telehealth services in the region, an innovation that enabled the healthcare industry to continue providing high-quality, affordable care to families through the crisis.

Lim Wai Mun, founder and CEO of Doctor Anywhere, said, “DA’s mission is to be the largest tech-enabled omnichannel healthcare provider in Southeast Asia, and applying innovative technology to improving patient outcomes is core to our differentiated offerings. We are thrilled to attract the interest of a strong group of investors in this round, a significant milestone which is a testament to our vision and track record.”

DA has built a strong ecosystem of payers, providers, and patients across its core markets. It has close to 2,800 doctors and medical professionals within its network in the region, and it also works closely with major hospitals and healthcare institutions.

This latest investment will significantly bolster DA’s market leadership and put the group in a leading position to further deepen its presence in its existing markets. It will also allow the group to expand into new markets, to drive its mission of transforming the regional healthcare landscape through technology.

“We will utilise this funding to further enhance our digital capabilities, and scale up on our ability to deliver quality healthcare seamlessly to our users in Southeast Asia,” added Lim.

“We are deeply impressed by what Wai Mun and his team have accomplished in such a short period of time,” said Oliver M. Rippel, a co-founder of Asia Partners. “As our region’s leading omnichannel healthcare innovator, DA is helping the healthcare industry rise to the occasion for the challenges and opportunities in the decade ahead. We are proud to be partnering with DA to support its continued growth.”

Kien T. Nguyen, a co-founder of Asia Partners, added, “DA is becoming a true regional leader in omnichannel healthcare, following the proven regionalisation playbook of Southeast Asia’s first generation of internet platform companies. The powerful combination of telehealth and offline care is deeply compelling to payers, providers, and patients across our region of 650 million people, and DA is leading the way.”

Dr. Amit Kakar, Senior Partner, Head of Novo Holdings Equity Asia, said: “We are very pleased to invest in DA and to support its mission to transform the regional healthcare landscape through technology. The pandemic accelerated a trend that was already gaining traction – the delivery of high quality, cost-effective and highly accessible healthcare through digital means, regardless of where the patients are located. DA offers a leading approach to combining the online and offline realms of healthcare through an omnichannel strategy, bringing the delivery of patient care to the next level of tech-led healthcare. We look forward to leveraging this momentum and continuing to work with Wai Mun and his team, true leaders in this space.”

Doctor Anywhere is currently available in Singapore, Malaysia, Thailand, Vietnam, and the Philippines. The group also recently announced the establishment of regional tech hubs in Bangalore, India, and Ho Chi Minh City, Vietnam.


Source: Doctor Anywhere

NEWS CRUNCH  
news Asia Summit on Global Health (ASGH) 2021 — Shaping a Resilient and Sustainable Future
news TechInnovation 2021 Virtual Exhibition to Showcase Sustainable Energy, Food, and Healthcare Solutions
news A New Approach for Effective Gout Treatment
news TechInnovation Returns from 28 to 30 September 2021
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy